These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 7062202)
41. Kawasaki disease shock syndrome or toxic shock syndrome in children and the relationship with COVID-19. Pruc M; Smereka J; Dzieciatkowski T; Jaguszewski M; Filipiak KJ; Szarpak L Med Hypotheses; 2020 Nov; 144():109986. PubMed ID: 32562912 [TBL] [Abstract][Full Text] [Related]
43. Manifestations of Kawasaki disease in New England outbreak of 1980. Meade RH; Brandt L J Pediatr; 1982 Apr; 100(4):558-62. PubMed ID: 7062203 [TBL] [Abstract][Full Text] [Related]
44. Kawasaki syndrome in the United States 1976 to 1980. Bell DM; Morens DM; Holman RC; Hurwitz ES; Hunter MK Am J Dis Child; 1983 Mar; 137(3):211-4. PubMed ID: 6823918 [TBL] [Abstract][Full Text] [Related]
45. Kawasaki disease in Canterbury. Morgan GJ; Lynch MA Arch Dis Child; 1978 Nov; 53(11):916-7. PubMed ID: 727818 [No Abstract] [Full Text] [Related]
49. Re: Kawasaki disease in Melbourne. Menahem S Aust Paediatr J; 1980 Sep; 16(3):160. PubMed ID: 7224990 [No Abstract] [Full Text] [Related]
50. Epidemiologic study of Kawasaki disease in Korea. Lee DB Prog Clin Biol Res; 1987; 250():55-60. PubMed ID: 3423071 [TBL] [Abstract][Full Text] [Related]
51. Epidemiologic aspects of Kawasaki disease in a Manhattan hospital. Ichida F; Fatica NS; O'Loughlin JE; Klein AA; Snyder MS; Levin AR; Ehlers KH; Lesser ML; Engle MA Pediatrics; 1989 Aug; 84(2):235-41. PubMed ID: 2748250 [TBL] [Abstract][Full Text] [Related]
56. Salicylate treatment of epidemic Kawasaki disease in New York City. Jacobs JC Ther Drug Monit; 1979; 1(1):123-30. PubMed ID: 553328 [TBL] [Abstract][Full Text] [Related]
57. Mucocutaneous lymph node syndrome in a young adult. Lee TJ; Vaughan D Arch Intern Med; 1979 Jan; 139(1):104-5. PubMed ID: 760673 [TBL] [Abstract][Full Text] [Related]